| ADDEX THERAP.ADR NEW/120 |
| USA |
| Gesundheit |
| US00654J2069 / A3EXC6 |
| APE1 (Frankfurt) / ADXN (NASDAQ) |
| FRA:APE1, ETR:APE1, APE1:GR, NASDAQ:ADXN |
| - |
| http://www.addextherapeut.. |
|
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland. The company specializes in the discovery, development, and commercialization of novel small-molecule drugs known as allosteric modulators, whic..
>Volltext.. |
| 5.52 Mio. EUR |
| 4.61 Mio. EUR |
| 0.12 Mio. EUR |
| -2.91 Mio. EUR |
| -7.61 Mio. EUR |
| -8.16 EUR |
| 0.11 Mio. EUR |
| 1.02 Mio. EUR |
| -2.58 Mio. EUR |
| 0.77 |
| -50.79% |
| -191.75% |
| - |
| - |
| - |
| - |
| ADDEX ADR, ADDEX |
| 08.07.26 |
|
||||
|
||||
|